Ambu A/S (AMBBY)
OTCMKTS · Delayed Price · Currency is USD
15.30
-0.44 (-2.80%)
At close: Jul 29, 2025
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of $3.79 billion as of August 1, 2025. Its market cap has decreased by -27.54% in one year.
Market Cap
3.79B
Enterprise Value
3.78B
Revenue
845.29M
Ranking
n/a
PE Ratio
70.67
Stock Price
$15.30
Market Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 46.64M to 3.79B, an increase of 8,022.15%. That is a compound annual growth rate of 15.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 3.79B | -1.74% |
| Dec 30, 2024 | 3.86B | -7.19% |
| Dec 29, 2023 | 4.15B | 27.87% |
| Dec 30, 2022 | 3.25B | -51.40% |
| Dec 30, 2021 | 6.68B | -37.96% |
| Dec 30, 2020 | 10.78B | 161.77% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 366.82M |